Literature DB >> 20825296

Treatment of Graves' disease with antithyroid drugs: current perspectives.

Kristien Boelaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20825296     DOI： 10.1089/thy.2010.1654

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  5 in total

Review 1.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

2.  A second course of antithyroid drug therapy for recurrent Graves' disease: an experience in endocrine practice.

Authors:  Xiaomei Liu; Wei Qiang; Xingjun Liu; Lianye Liu; Shu Liu; Aibo Gao; Shan Gao; Bingyin Shi
Journal:  Eur J Endocrinol       Date:  2014-12-02       Impact factor: 6.664

3.  TSH Receptor Signaling Abrogation by a Novel Small Molecule.

Authors:  Rauf Latif; Ronald B Realubit; Charles Karan; Mihaly Mezei; Terry F Davies
Journal:  Front Endocrinol (Lausanne)       Date:  2016-09-27       Impact factor: 5.555

4.  Epidemiology, management and outcomes of Graves' disease-real life data.

Authors:  Y S Hussain; J C Hookham; A Allahabadia; S P Balasubramanian
Journal:  Endocrine       Date:  2017-05-06       Impact factor: 3.633

5.  A study of serum IgG4 levels in the clinical metamorphosis of autoimmune thyroid disease.

Authors:  Yotsapon Thewjitcharoen; Sirinate Krittiyawong; Sriurai Porramatikul; Ekgaluck Wanothayaroj; Nampetch Lekpittaya; Jirapat Jeamjiraprasert; Soontaree Nakasatien; Thep Himathongkam
Journal:  J Clin Transl Endocrinol       Date:  2017-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.